Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | CTSC | P53634 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PRCP | P42785 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34461082 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL8526749 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL8526747 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| Hydrochloric Acid SCHEMBL17222183 | 0.98 | DPP7 (0.46) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL31023074 | 0.94 | DPP7 (0.43) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30356632 | 0.90 | DPP7 (0.42) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30729221 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30729269 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL10537153 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL6401404 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118340935-A | Recombinant collagen composite gel, dressing and application thereof | 湖南慕她生物科技发展有限公司湘潭分公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117337971-B | Composition containing pilose antler and preparation method and application thereof | 玺瑞生命科学(深圳)有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117779036-A | Copper etching solution | 合肥中聚和成电子材料有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-116162926-A | Copper surface antioxidant composition and preparation method thereof | 深圳市正天伟科技有限公司 | 2023-05-26 | — | — | CN | claimed |
| EP-4500182-A1 | PROGNOSTIC BIOMARKERS | The University of Liverpool (GB) | 2025-02-05 | — | — | EP | disclosed |
| CN-117337971-B | Composition containing pilose antler and preparation method and application thereof | 玺瑞生命科学(深圳)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117281955-A | Preparation method of valve stent surface coating with good biocompatibility | 南京圣德医疗科技有限公司 | 2023-12-26 | — | — | CN | disclosed |
| WO-2023180753-A1 | PROGNOSTIC BIOMARKERS | THE UNIVERSITY OF LIVERPOOL (GB) | 2023-09-28 | — | — | WO | disclosed |
| CN-116162926-A | Copper surface antioxidant composition and preparation method thereof | 深圳市正天伟科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-11382911-B2 | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LIMITED (JP) | 2022-07-12 | — | — | US | disclosed |
| US-20180325893-A1 | SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION | UNIV NORTHWESTERN (US) | 2018-11-15 | — | — | US | disclosed |
| EP-2771021-B1 | NMDA RECEPTOR MODULATORS AND USES THEREOF | NORTH WESTERN UNIV (US) | 2018-08-29 | — | — | EP | disclosed |
| US-20180237474-A1 | NMDA RECEPTOR MODULATORS AND USES THEREOF | INNOVIVA TRC HOLDINGS LLC | 2018-08-23 | — | — | US | disclosed |
| US-20160368947-A1 | NMDA Receptor Modulators and Uses Thereof | INNOVIVA TRC HOLDINGS LLC | 2016-12-22 | — | — | US | disclosed |
| US-20150315237-A1 | NMDA Receptor Modulators and Uses Thereof | NORTHWESTERN UNIVERSITY | 2015-11-05 | — | — | US | disclosed |
| US-20150051262-A1 | NMDA RECEPTOR MODULATORS AND USES THEREOF | NORTHWESTERN UNIVERSITY (US) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051262-A1 | NMDA RECEPTOR MODULATORS AND USES THEREOF | GRIN1, GRIN2A, GRIN3A | DPP7 1502/4885CTSC 2342/4885CYP3A4 3302/4885 |
| US-20150315237-A1 | NMDA Receptor Modulators and Uses Thereof | GRIN1, GRIN2A, GRIN3A | DPP7 1502/4885CTSC 2342/4885CYP3A4 3302/4885 |
| US-20160368947-A1 | NMDA Receptor Modulators and Uses Thereof | GRIN1, GRIN2A, GRIN3A | DPP7 1502/4885CTSC 2342/4885CYP3A4 3302/4885 |
| US-20180325893-A1 | SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION | GRIN2A, GRIN2D, GRIN1 | DPP7 3634/4885CTSC 3420/4885CYP3A4 3146/4885 |
| US-20180237474-A1 | NMDA RECEPTOR MODULATORS AND USES THEREOF | GRIN1, GRIN2A, GRIN3A | DPP7 1502/4885CTSC 2342/4885CYP3A4 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.